The Life and Longevity Markets Association (LLMA) has released a framework for pricing general longevity derivatives, in the hope of making the market more accessible to participants on both the hedging and investment sides of the transaction.
The industry body presents an approach to pricing the securities, based on a recipe of adjusting the nominal cash flows for the historical mortality, its expected improvement and a risk premium, then taking an average over a suitable scenario set.
The week on Risk.net, October 6-12, 2017Receive this by email
- SGX, HKEX expect to be among first wave of Mifid II equivalence
- Leaked EU doc could shield legacy swaps from clearing grab
- ABS set for revival under US Treasury’s liquidity buffer plans
- Quantile, TriOptima face off in cleared swaps compression battle
- Quants stymied by lack of alternative risk premia flows data